News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Global.
RELATED STOCKHEAD STORIES
News
Closing Bell: Staples go stupid as ASX200 proves it’s no Dow Jones, but it can be average
News
ASX Small Cap Lunch Wrap: Awful iron ore and earnings avalanche pin ASX to the ordinary
News
ASX Small Caps and IPO Weekly Wrap: The week we learned what Woolies is really worth
News
Closing Bell: Aussie benchmark fails Tuesday pub test. We should all be there now
News
ASX Small Caps News Wrap: Who’s taking full responsibility by firing 1500 people this week?
News
Top 10 at 11: Half-year results and lithium hits are tipping the scales this morning
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX climbs ahead of Australia’s Richest Morning Tea™ tomorrow at the RBA
News
Banking on pot: Minus one global investment house, Switzerland moves to legalise cannabis
Health & Biotech
Weed Week: Musk gives the go-ahead for cannabis advertising on Twitter in the US
News
Trading Places: Rinehart makes play for Warrego Energy, Whitehaven gets new substantial shareholder
News
ASX Small Caps Lunch Wrap: Who else wants to bust up monopolies this morning?
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
Weed Week: Will the US Senate pass the MORE act, and Swiss cannabis wellness spas are a thing
Health & Biotech
California just passed a bill to legalise hemp – and there are ASX cannabis stocks that could benefit
Health & Biotech